Curated News
By: NewsRamp Editorial Staff
October 20, 2026
TreVita Sees 127% Surge in Plastic Surgery Interest, 19% Rise in Male Clients
TLDR
- TreVita's 127% plastic surgery program growth and 19% rise in male clients signal a competitive edge in medical travel.
- TreVita verifies practitioners through a five-step process including credential checks, history review, and in-person facility evaluations.
- TreVita expands access to vetted cosmetic care abroad, helping more people address weight-loss changes and improve well-being.
- GLP-1 weight-loss medications are linked to rising body contouring procedures like upper body lifts, which increased 22% in 2025.
Impact - Why it Matters
This news matters because it signals a significant shift in the medical travel industry and cosmetic surgery demographics. The surge in interest—particularly among men and patients addressing post-weight-loss body contouring—highlights how GLP-1 medications and changing social attitudes are reshaping demand. As more Americans consider traveling abroad for care, TreVita's rigorous verification process addresses critical safety concerns, offering a trusted pathway for patients seeking affordable, high-quality procedures. The expansion into Colombia and Mexico reflects a growing normalization of medical travel, which could pressure U.S. providers to compete on price and transparency while giving patients more options for personalized care.
Summary
TreVita, a U.S.-based medical travel company headquartered in San Diego, has announced a 127% year-over-year increase in interest in its plastic surgery program, alongside a 19% increase in male clients. The company attributes this growth to a broader demographic of patients considering cosmetic procedures and a rising trend of Americans traveling abroad for care. The announcement comes as cosmetic surgical procedures in the U.S. increased 7% in 2025, according to the American Society of Plastic Surgeons (ASPS), with liposuction, breast augmentation, and tummy tucks among the most in-demand procedures. Globally, more than 35 million surgical and nonsurgical aesthetic procedures were performed in 2025, per the International Society of Aesthetic Plastic Surgery (ISAPS), with men accounting for over 14% of surgical procedures worldwide.
TreVita is also seeing demand evolve with the widespread adoption of GLP-1 weight-loss medications. Significant weight loss can leave patients with excess skin, driving interest in body-contouring procedures. In 2025, 82% of ASPS member surgeons reported consultation requests related to GLP-1 use, and procedures such as upper body lifts (up 22%), arm lifts (up 21%), thigh lifts (up 20%), and breast lifts (up 8%) saw notable increases. “Plastic surgery is becoming relevant to a much broader group of people than it was even a few years ago,” said Blake Schroeder, CEO of TreVita. “We’re seeing that firsthand, from more men exploring procedures to patients looking to address changes after significant weight loss.”
To meet growing demand, TreVita continues to expand its network of TreVita Verified medical practitioners, currently working with five verified facilities in Zona Río, Mexico, and a partner clinic in Cartagena, Colombia. Each facility undergoes a rigorous five-step vetting process, including independent verification of credentials, review of professional history, and in-person evaluations. “TreVita Verified is our answer to ‘How do I know who I can trust?’” Schroeder added. Beyond plastic surgery, TreVita offers bariatric surgery, hair restoration, and regenerative medicine, providing end-to-end support. For more information, visit TreVita Plastic Surgery.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, TreVita Sees 127% Surge in Plastic Surgery Interest, 19% Rise in Male Clients
